Cargando…

Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation

Human primary cells, including urine-derived cells (UCs), are an excellent source for generation of pluripotent stem cells (iPSCs) to model disease. However, replicative senescence starts early and shortens the time window for generation of iPSCs. We addressed the question whether combinations of tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiand, Matthias, Ballmaier, Paula, Niemietz, Christoph, Schmidt, Hartmut, Zibert, Andree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294256/
https://www.ncbi.nlm.nih.gov/pubmed/35865272
http://dx.doi.org/10.1016/j.bbrep.2022.101308
_version_ 1784749810093391872
author Weiand, Matthias
Ballmaier, Paula
Niemietz, Christoph
Schmidt, Hartmut
Zibert, Andree
author_facet Weiand, Matthias
Ballmaier, Paula
Niemietz, Christoph
Schmidt, Hartmut
Zibert, Andree
author_sort Weiand, Matthias
collection PubMed
description Human primary cells, including urine-derived cells (UCs), are an excellent source for generation of pluripotent stem cells (iPSCs) to model disease. However, replicative senescence starts early and shortens the time window for generation of iPSCs. We addressed the question whether combinations of transgenes allows efficient immortalization of UCs, iPSC generation, and differentiation into hepatocyte-like cells (HLCs). Retroviral transfer of three gene cassettes HPVE6E7 (H), hTERT/p53DD (T), cyclinD1/CDK4R24C (C) encoding five genes was established in primary UCs. Long-term cell proliferation was observed in cells carrying transgenes H, HT, HC, and HCT, whereas cells carrying transgenes C, T and CT showed early senescence similar to UCs. iPSCs could be exclusively generated from immortalized UCs transduced with transgenes HCT and HC. iPSC colonies appeared however later and in smaller number as compared to UCs. Using an established hepatic differentiation protocol, HLCs were obtained with high efficacy. Of note, a high expression of individual transgenes was observed in immortalized UCs, which was down-regulated after reprogramming in four out of five genes. One transgene was re-expressed in HLCs as compared to iPSCs. Our data suggest that individual transgene combinations result in advanced growth rates of immortalized cells and do not prevent iPSC formation and HLC differentiation. Retroviral transgene expression is mostly silenced in iPSCs but can be rarely re-expressed after hepatic differentiation. An extended time window for iPSC establishment can be proposed that allows straightforward functional analyses of differentiated cells.
format Online
Article
Text
id pubmed-9294256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92942562022-07-20 Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation Weiand, Matthias Ballmaier, Paula Niemietz, Christoph Schmidt, Hartmut Zibert, Andree Biochem Biophys Rep Research Article Human primary cells, including urine-derived cells (UCs), are an excellent source for generation of pluripotent stem cells (iPSCs) to model disease. However, replicative senescence starts early and shortens the time window for generation of iPSCs. We addressed the question whether combinations of transgenes allows efficient immortalization of UCs, iPSC generation, and differentiation into hepatocyte-like cells (HLCs). Retroviral transfer of three gene cassettes HPVE6E7 (H), hTERT/p53DD (T), cyclinD1/CDK4R24C (C) encoding five genes was established in primary UCs. Long-term cell proliferation was observed in cells carrying transgenes H, HT, HC, and HCT, whereas cells carrying transgenes C, T and CT showed early senescence similar to UCs. iPSCs could be exclusively generated from immortalized UCs transduced with transgenes HCT and HC. iPSC colonies appeared however later and in smaller number as compared to UCs. Using an established hepatic differentiation protocol, HLCs were obtained with high efficacy. Of note, a high expression of individual transgenes was observed in immortalized UCs, which was down-regulated after reprogramming in four out of five genes. One transgene was re-expressed in HLCs as compared to iPSCs. Our data suggest that individual transgene combinations result in advanced growth rates of immortalized cells and do not prevent iPSC formation and HLC differentiation. Retroviral transgene expression is mostly silenced in iPSCs but can be rarely re-expressed after hepatic differentiation. An extended time window for iPSC establishment can be proposed that allows straightforward functional analyses of differentiated cells. Elsevier 2022-07-16 /pmc/articles/PMC9294256/ /pubmed/35865272 http://dx.doi.org/10.1016/j.bbrep.2022.101308 Text en © 2022 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Weiand, Matthias
Ballmaier, Paula
Niemietz, Christoph
Schmidt, Hartmut
Zibert, Andree
Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title_full Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title_fullStr Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title_full_unstemmed Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title_short Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
title_sort combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294256/
https://www.ncbi.nlm.nih.gov/pubmed/35865272
http://dx.doi.org/10.1016/j.bbrep.2022.101308
work_keys_str_mv AT weiandmatthias combinedtransgeneimmortalizedurothelialcellscapableofreprogrammingandhepaticdifferentiation
AT ballmaierpaula combinedtransgeneimmortalizedurothelialcellscapableofreprogrammingandhepaticdifferentiation
AT niemietzchristoph combinedtransgeneimmortalizedurothelialcellscapableofreprogrammingandhepaticdifferentiation
AT schmidthartmut combinedtransgeneimmortalizedurothelialcellscapableofreprogrammingandhepaticdifferentiation
AT zibertandree combinedtransgeneimmortalizedurothelialcellscapableofreprogrammingandhepaticdifferentiation